20.27
前日終値:
$19.55
開ける:
$20.21
24時間の取引高:
348.37K
Relative Volume:
0.96
時価総額:
$1.13B
収益:
-
当期純損益:
$-125.38M
株価収益率:
-3.8663
EPS:
-5.2427
ネットキャッシュフロー:
$-98.65M
1週間 パフォーマンス:
+4.22%
1か月 パフォーマンス:
-8.82%
6か月 パフォーマンス:
+128.01%
1年 パフォーマンス:
+405.49%
Dbv Technologies Adr Stock (DBVT) Company Profile
名前
Dbv Technologies Adr
セクター
電話
33(0)155427878
住所
107 AVENUE DE LA REPUBLIQUE, CHATILLON
Compare DBVT vs VRTX, REGN, ALNY, ARGX, INSM
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
DBVT
Dbv Technologies Adr
|
20.27 | 1.09B | 0 | -125.38M | -98.65M | -5.2427 |
|
VRTX
Vertex Pharmaceuticals Inc
|
454.97 | 113.96B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
749.47 | 78.41B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.70 | 40.85B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ARGX
Argen X Se Adr
|
697.05 | 42.05B | 4.16B | 1.29B | 734.26M | 19.58 |
|
INSM
Insmed Inc
|
148.31 | 29.99B | 606.42M | -1.28B | -997.58M | -6.403 |
Dbv Technologies Adr Stock (DBVT) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-15 | 開始されました | Cantor Fitzgerald | Overweight |
| 2025-12-03 | 開始されました | Guggenheim | Buy |
| 2025-05-29 | 再開されました | Goldman | Sell |
| 2023-01-04 | アップグレード | Societe Generale | Hold → Buy |
| 2022-12-16 | ダウングレード | Goldman | Neutral → Sell |
| 2022-05-10 | ダウングレード | Goldman | Buy → Neutral |
| 2021-09-14 | アップグレード | Societe Generale | Hold → Buy |
| 2021-01-22 | ダウングレード | Societe Generale | Hold → Sell |
| 2020-11-02 | アップグレード | Societe Generale | Sell → Hold |
| 2020-08-06 | ダウングレード | Societe Generale | Buy → Sell |
| 2020-08-05 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-03-17 | ダウングレード | Stifel | Buy → Hold |
| 2020-01-09 | アップグレード | Stifel | Hold → Buy |
| 2019-12-16 | 開始されました | Citigroup | Buy |
| 2019-09-05 | 再開されました | Morgan Stanley | Equal-Weight |
| 2019-06-17 | 開始されました | Goldman | Buy |
| 2018-12-20 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2018-12-20 | ダウングレード | BofA/Merrill | Buy → Underperform |
| 2018-12-20 | ダウングレード | Jefferies | Buy → Hold |
| 2018-12-20 | ダウングレード | Stifel | Buy → Hold |
| 2017-10-31 | アップグレード | Societe Generale | Sell → Hold |
| 2017-10-24 | ダウングレード | Societe Generale | Buy → Sell |
| 2017-10-23 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2017-06-23 | 開始されました | Deutsche Bank | Buy |
| 2017-03-16 | アップグレード | Societe Generale | Hold → Buy |
| 2016-09-26 | 開始されました | JMP Securities | Mkt Outperform |
| 2015-12-03 | 開始されました | Barclays | Overweight |
| 2015-10-23 | 開始されました | BofA/Merrill | Buy |
すべてを表示
Dbv Technologies Adr (DBVT) 最新ニュース
Hesai Group, BitFuFu And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Sahm
DBV Technologies to Join CAC Mid 60 and SBF 120 Indices Following Euronext Paris Annual Review - Bitget
DLD Asset Management LP Makes New $250,000 Investment in DBV Technologies S.A. $DBVT - Defense World
Analysts Offer Insights on Healthcare Companies: ArriVent BioPharma, Inc. (AVBP), Chemomab Therapeutics (CMMB) and Reviva Pharmaceuticals Holdings (RVPH) - The Globe and Mail
DBV Technologies to Participate in Upcoming March Investor Conferences - markets.businessinsider.com
Biotech DBV Technologies lines up back-to-back March investor events - Stock Titan
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of February 28, 2026 - ChartMill
DBV Technologies stock surges on new peanut patch trial data - Investing.com
Phase 3 VITESSE data highlighted by DBV Technologies (NASDAQ: DBVT) - Stock Titan
DBV Technologies Highlights Additional Data from Successful Phase 3 VITESSE Study at the AAAAI 2026 Annual Meeting - The Manila Times
DBV Technologies Highlights Additional Data from Successful - GlobeNewswire
DBV Technologies (DBVT) Projected to Post Earnings on Thursday - Defense World
European ADRs Were Flat As Biotech Names Took The Lead - Finimize
Analysts Offer Insights on Healthcare Companies: Iovance Biotherapeutics (IOVA) and Palvella Therapeutics (PVLA) - The Globe and Mail
DBV Technologies launches $150M ATM offering - MSN
BioImpact LLC reports 9.99% DBV Technologies (DBVT) stake via shares and warrants - Stock Titan
European Equities Traded in the US as American Depositary Receipts Lower Wednesday - MSN
DBV Technologies to Participate in Biotech Summit - Intellectia AI
DBV Technologies to Present VIASKIN® Data at AAAAI 2026 - Intellectia AI
DBV Technologies to Present Additional Data from the VITESSE Phase 3 Study of the VIASKIN® Peanut Patch in Children Ages 4-7 Years and Discuss Future of EPIT in the Treatment Landscape at AAAAI 2026 Annual Meeting - The Manila Times
DBV Technologies S.A. - Via Ritzau
Peanut allergy patch data in young children to get spotlight at AAAAI 2026 - Stock Titan
DBV Technologies to Participate in the Guggenheim Securities Emerging Outlook: Biotech Summit - markets.businessinsider.com
Biotech summit to feature DBV Technologies CEO fireside chat - Stock Titan
DBV Technologies (NASDAQ:DBVT) Upgraded at Wall Street Zen - Defense World
DBV Technologies S.A. (NASDAQ:DBVT) Receives Consensus Rating of “Moderate Buy” from Brokerages - Defense World
European ADRs Slip As Winners And Losers Split By Region - Finimize
European ADRs Inched Higher As GSK And Telefonica Jumped - Finimize
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Galecto (GLTO), Roche Holding AG (OtherRHHVF) and Amgen (AMGN) - The Globe and Mail
Guggenheim reiterates Buy rating on DBV Technologies stock with $51 target - Investing.com
DBV Technologies (NASDAQ:DBVT) Stock Price Passes Above 50 Day Moving Average – What’s Next? - Defense World
European ADRs Started The Week Higher In US Trading - Finimize
DBV Technologies Announces €166.7 Million in Gross Proceeds Following the Full Exercise of the ABSA Warrants and BS Warrants Issued on its March 2025 Financing - Sahm
DBV Technologies (NASDAQ:DBVT) Shares Gap Up – Still a Buy? - Defense World
European ADRs Slipped, But Biotech Names Still Stole The Show - Finimize
DBV Technologies Announces €166.7 Million in Gross Proceeds - GlobeNewswire
DBV Technologies annonce avoir reçu un produit brut de 166,7 millions d'euros suite à l'exercice intégral des Bons de Souscription (BS) issus des ABSAs et des BS issus des PFW-BS-PFW émis dans le cadre de son financement de mars 2025 - GlobeNewswire Inc.
Worthington Steel, Immunitybio, Riot Platforms, Micron Technology And Other Big Stocks Moving Higher On Friday - Benzinga
Dbv Technologies Adr (DBVT) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):